Vioxx Litigation
Vioxx, also know as rofecoxib, was approved by the FDA on November 2001 and went to market in March 2002.  Vioxx is made by Merck.  In 2002, the U.S. Food and Drug Administration (FDA) issued a warning about Vioxx.  The FDA has received about 20 reports of serious reactions among Vioxx users since sales began.  The FDA also mandated product label changes for Vioxx.  Merck, the manufacturer of Vioxx, sent letters to thousands of physicians alerting them to the new warnings.

Vioxx was prescribed for the relief of symptoms of:

• Osteoarthritis (also known as “wear and tear” arthritis, a degenerative joint disease common in older people)

• Adult rheumatoid arthritis (a sever form of arthritis which affects over 2 million people)

• Primary dysmennorhea (server menstrual cramping)

Vioxx and Heart Attacks
Recent studies have shown that Vioxx can increase the incidence of heart attack nearly four times greater than that of traditional arthritis pain relievers like NSAIDS.  More specifically, the new study out of the Cleveland Clinic noted an increase in the development of myocardial infarctions, or heart attacks, in people treated with Vioxx, when compared with those treated with naproxen (a standard NSAID).  While the risk of heart attack is still low, it is a concern for those users who may have had cardiac problems in the past.

The personal injury attorneys at Thurlow & Associates, P.C. can represent you in vioxx litigation. As in all personal injury cases, time is of the essence.

Call us toll-free at 1-866-685-8326 or click here to contact us now.